Section 44-10-208 - Feasibility report - standing committee - definition - repeal(1)(a) On or before July 1, 2024, the executive director shall submit to the general assembly a report analyzing the feasibility of establishing a standing committee to evaluate cannabinoids and cannabis-derived products for the purpose of determining and making recommendations regarding their safety profiles and potential for intoxication. The report must consider and recommend legislative action addressing the following subjects: (I) The appropriate state agency or agencies to be involved in, and their role in, the evaluation process;(II) The ability of a standing committee to determine safety profiles of cannabinoids and cannabis-derived products, including the process by which a standing committee would make such a determination;(III) The ability of a standing committee to determine the potential for intoxication of cannabinoids and cannabis-derived products, including the process by which a standing committee would make such a determination;(IV) Recommendations as to members of a standing committee and a process to make appointments of members to a standing committee;(V) Recommendations regarding an operable timeline for implementation of a standing committee; and(VI) The fiscal effects of and the resources needed to implement and administer a standing committee.(b) To inform the feasibility report described in subsection (1)(a) of this section, the department may engage experts, including:(I) The chief medical officer appointed pursuant to section 25-1-105 or the designee of the chief medical officer;(II) The state toxicologist or the designee of the state toxicologist;(III) An epidemiologist with expertise in designing and conducting observational studies or clinical trials;(IV) A clinician familiar with dosage forms and routes of administration of relevant products;(V) A medical toxicologist; and(VI) A pharmacologist with expertise in drug development.(2) As used in this section, "state toxicologist" means the director of the toxicology and environmental epidemiology office, or a successor office, in the department of public health and environment.(3) This section is repealed, effective July 1, 2025.Added by 2023 Ch. 444,§ 4, eff. 6/7/2023.